Global Research Trends on the Treatment of Diffuse Large B-Cell Lymphoma: A Bibliometric and Visualized Study

被引:4
|
作者
Duan, Qintong [1 ]
Li, Yufeng [1 ]
Ou, Lijia [1 ]
Li, Yajun [2 ]
Zeng, Ruolan [2 ]
He, Yizi [2 ]
Pan, Tao [2 ]
Chen, Siwei [1 ]
Chen, Huan [3 ]
Zang, Hui [4 ]
Zhou, Hui [2 ]
Xiao, Ling [1 ]
机构
[1] Cent South Univ, Dept Histol & Embryol, Sch Basic Med Sci, Changsha, Hunan, Peoples R China
[2] Cent South Univ, Xiangya Med Sch, Affiliated Tumor Hosp, Dept Lymphoma & Hematol, Changsha, Hunan, Peoples R China
[3] Hunan Univ Med, Sch Basic Med Sci, Dept Pathol & Pathophysiol, Huaihua 418000, Peoples R China
[4] Yiyang Med Coll, Dept Human Anat & Histoembryol, Sch Basic Med Sci, Yiyang, Peoples R China
来源
JOURNAL OF CANCER | 2022年 / 13卷 / 05期
基金
中国国家自然科学基金;
关键词
Key words; diffuse large B-cell Lymphoma (DLBCL); treatment; research progress; bibliometric analysis; Visualized; VOSviewer; PUBLIC-HEALTH RESEARCH; R-CHOP; PHASE-III; FRONTLINE RITUXIMAB; INFECTIOUS-DISEASES; SALVAGE REGIMENS; TRANSPLANTATION; LENALIDOMIDE; TRIAL; CYCLOPHOSPHAMIDE;
D O I
10.7150/jca.68453
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Diffuse large B-cell lymphoma (DLBCL) is the most common lymphoma subtype. Treatment of DLBCL has improved greatly in recent decades, with thousands of papers published. We conducted a bibliometric analysis of the literature on DLBCL treatment, and discussed cooperation among authors, countries, and institutions, and identified research hotspots for DLBCL treatment. We searched the Web of Science Core Collection (WOSCC) using "Diffuse Large B Cell Lymphoma or DLBCL" and "Treatment or Therapy or Clinical Trial" as the subject terms, and analyzed the publication year, research direction, country/region, institution, author, source publication, distribution of funding institutions, and other conditions provided by the database. In addition, scientometrics software was used to analyze literature citations and cooperative publications. Bibliometric analyses were performed using https://bibliometric.com/app and VOSviewer. Network maps were generated to evaluate collaborations between different authors, countries, institutions, and keywords. A total of 7,255 studies on treatment of DLBCL were retrieved from the WOSCC on February 19, 2021. We found that the number of publications increased gradually from 1999 to 2021, and this trend was relatively stable in the past 3 years. The countries that produced the most publications were the United States, China, and Japan. Among institutions, University of Texas MD Anderson Cancer Center published the most manuscripts. Furthermore, the United States also had the most annual publications, citations, distribution of journal sources, and funding. Cooperative research between countries is also relatively important to treatment of DLBCL. Therapeutic regimens such as CHOP and R-CHOP, and immunotherapy (CAR-T, PD1/PDL1, and CAR-NK, etc.), have received increased attention. Bibliometric analysis of studies related to DLBCL treatment can help researchers and clinical workers quickly understand the hotspots and development trends in this field, and provide reference for the formulation of public health policies.
引用
收藏
页码:1785 / 1795
页数:11
相关论文
共 50 条
  • [1] Treatment of diffuse large B-cell lymphoma
    Gleissner, B.
    Zwick, C.
    Pfreundschuh, M.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2008, 133 (36) : 1785 - 1794
  • [2] Diffuse large B-cell lymphoma
    Barraclough, Allison
    Hawkes, Eliza
    Sehn, Laurie H.
    Smith, Sonali M.
    HEMATOLOGICAL ONCOLOGY, 2024, 42 (06)
  • [3] Global Research Trends on Monkeypox Virus: A Bibliometric and Visualized Study
    Zeeshan, Hafiz Muhammad
    Rubab, Aqsa
    Dhlakama, Hilda
    Ogunsakin, Ropo Ebenezer
    Okpeku, Moses
    TROPICAL MEDICINE AND INFECTIOUS DISEASE, 2022, 7 (12)
  • [4] Treatment of elderly patients with diffuse large B-cell lymphoma
    Nösslinger T.
    memo - Magazine of European Medical Oncology, 2016, 9 (1) : 8 - 12
  • [5] Global research trends of acupuncture therapy on cancer pain: A bibliometric and visualized study
    Li, Chunyu
    Zhao, Can
    Zhao, Jingjing
    Wang, Min
    Luo, Furong
    Zhou, Jianwei
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [6] Diffuse Large B-cell Lymphoma in the elderly: standard treatment and new perspectives
    Chiappella, Annalisa
    Castellino, Alessia
    Nicolosi, Maura
    Santambrogio, Elisa
    Vitolo, Umberto
    EXPERT REVIEW OF HEMATOLOGY, 2017, 10 (04) : 289 - 297
  • [7] Pembrolizumab for the treatment of diffuse large B-cell lymphoma
    Sheikh, Semira
    Kuruvilla, John
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2019, 19 (11) : 1119 - 1126
  • [8] Pidilizumab in the treatment of diffuse large B-cell lymphoma
    Bryan, Locke J.
    Gordon, Leo I.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2014, 14 (09) : 1361 - 1368
  • [9] Treatment resistance in diffuse large B-cell lymphoma
    He, Michael Y.
    Kridel, Robert
    LEUKEMIA, 2021, 35 (08) : 2151 - 2165
  • [10] Diffuse large B-cell lymphoma with MYC gene rearrangements Current perspective on treatment of diffuse large B-cell lymphoma with MYC gene rearrangements; case series and review of the literature
    de Jonge, A. V.
    Roosma, T. J. A.
    Houtenbos, I.
    Vasmel, W. L. E.
    van de Hem, K.
    de Boer, J. P.
    van Maanen, T.
    Lindauer-van der Werf, G.
    Beeker, A.
    Timmers, G. J.
    Schaar, C. G.
    Soesan, M.
    Poddighe, P. J.
    de Jong, D.
    Chamuleau, M. E. D.
    EUROPEAN JOURNAL OF CANCER, 2016, 55 : 140 - 146